中文名稱:羅紅霉素 | 英文名稱:Roxithromycin |
CAS:80214-83-1 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.29% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T1151 |
名稱 | Roxithromycin |
描述 | Roxithromycin (RU-28965) is a semi-synthetic derivative of the macrolide antibiotic erythromycin with antibacterial and anti-malarial activities. |
激酶實(shí)驗(yàn) | The half-maximal inhibitory concentrations (IC50s) of Fenofibrate, statins (atorvastatin, lovastatin, pravastatin, simvastatin and simvastatin acid, the active form of simvastatin) and glipizide for recombinant human CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 are determined using fluorometric CYP450 inhibition assays. Briefly, the drugs are dissolved in methanol or acetonitrile. In 96 well assay plates, the drugs are diluted to a series of concentrations in a solution containing cofactors including NADP+ (final concentration 1.3 mM), MgCl2 (final concentration 3.3 m M), glucose-6-phosphate (G6P, final concentration 3.3 mM) and glucose 6-phosphate dehydrogenase (final concentration 0.4 U/mL). The mixture is pre-incubated at 37°C for 10 min. The enzymes and fluorogenic substrates are diluted to desired concentrations in sodium phosphate reaction buffer (pH 7.4, final concentration 200 mM) and mixed. Reactions are initiated with addition of the enzyme and substrate mixture to the cofactor and drug mixture. The final reaction volume of all assays is 200 μL. After incubating at 37°C for a pre-specified period of time (15 to 45 min), the reactions are stopped with addition of 75 μL quenching solution (0.5 M Tris base or 2N NaOH). Fluorescence is determined using a BioTek Synergy 2 fluorescence reader. Each of the drugs is tested at eight concentrations in duplicate. To estimate IC50s, percent of inhibition is calculated using net fluorescence that is corrected for the background. The values of percent of inhibition are then fitted to a three or four parameter log-logistic model[1]. |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | Ethanol : 154 mg/mL (184 mM) H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 60 mg/mL (71.68 mM) |
關(guān)鍵字 | Roxithromycin | RU 28965 | Inhibitor | Antibiotic | Bacterial | inhibit | RU28965 |
相關(guān)產(chǎn)品 | Neomycin sulfate | Dimethyl sulfoxide |
相關(guān)庫(kù) | 微生物天然產(chǎn)物庫(kù) | 經(jīng)典已知活性庫(kù) | 已知活性化合物庫(kù) | 抗菌活性庫(kù) | 抗寄生蟲庫(kù) | 藥物功能重定位化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.2651萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 化學(xué)試劑,生物活性小分子 | 經(jīng)營(yíng)模式 | 貿(mào)易,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥161 |
VIP6年
|
上海弘順生物科技有限公司
|
2024-11-16 | |
詢價(jià) |
VIP5年
|
武漢克米克生物醫(yī)藥技術(shù)有限公司
|
2024-11-16 | |
詢價(jià) |
VIP4年
|
四川省維克奇生物科技有限公司
|
2024-11-15 | |
詢價(jià) |
VIP4年
|
武漢東康源科技有限公司
|
2024-11-15 | |
¥1287 |
VIP4年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2024-11-15 | |
詢價(jià) |
VIP6年
|
湖北摩科化學(xué)有限公司
|
2024-11-15 | |
¥16500 |
VIP3年
|
湖北威德利化學(xué)試劑有限公司
|
2024-11-15 | |
詢價(jià) |
VIP9年
|
武漢維斯?fàn)柭锕こ逃邢薰?/div>
|
2024-11-15 | |
詢價(jià) |
VIP5年
|
武漢華玖醫(yī)藥科技有限公司
|
2024-11-15 | |
詢價(jià) |
VIP2年
|
武漢鼎程生科化學(xué)試劑有限公司
|
2024-11-15 |